Abstract
The release of H2O2 from alveolar macrophages has been linked to the development of pulmonary fibrosis, but little is known about its source or mechanism of production. We found that alveolar macrophages from asbestosis patients spontaneously produce high levels of H2O2 and have high expression of Cu,Zn-superoxide dismutase (SOD). Because Cu,Zn-SOD is found in the mitochondrial intermembrane space (IMS), we hypothesized that mitochondrial Cu,Zn-SOD-mediated H2O2 generation contributed to pulmonary fibrosis. Asbestos-induced translocation of Cu,Zn-SOD to the IMS was unique to macrophages and dependent on functional mitochondrial respiration and the presence of at least one of the conserved cysteines required for disulfide bond formation. These conserved cysteine residues were also necessary for enzyme activation and H2O2 generation. Cu,Zn-SOD-mediated H2O2 generation was inhibited by knockdown of the iron-sulfur protein, Rieske, in complex III. The role of Cu,Zn-SOD was biologically relevant in that Cu,Zn-SOD−/− mice generated significantly less H2O2 and had less oxidant stress in bronchoalveolar lavage fluid and lung parenchyma. Furthermore, Cu,Zn-SOD−/− mice did not develop pulmonary fibrosis, and knockdown of Cu,Zn-SOD in monocytes attenuated collagen I deposition by lung fibroblasts. Our findings demonstrate a novel mechanism for the pathogenesis of pulmonary fibrosis where the antioxidant enzyme Cu,Zn-SOD translocates to the mitochondrial IMS to increase H2O2 generation in alveolar macrophages.
Keywords: Collagen, Enzyme Mechanisms, Lung, Macrophage, Mitochondria, Oxidative Stress, Superoxide Dismutase (SOD), Pulmonary Fibrosis
Introduction
Pulmonary fibrosis is a progressive disease characterized by aberrant repair that results in remodeling and destruction of the normal architecture of lung tissue. Asbestos exposure is a prototypical cause of pulmonary fibrosis. Approximately 200,000 cases of asbestos-related pulmonary disease are diagnosed each year, leading to 4,000 deaths annually, despite tight regulatory controls to limit exposure (1). Although asbestos remains an important cause of pulmonary fibrosis, the mechanism for asbestos-induced lung injury is poorly understood.
Reactive oxygen species (ROS),2 including H2O2, play an important role in the pathogenesis of asbestos-mediated pulmonary fibrosis. Generation of ROS can occur in a cell-free system by the reduction of oxygen on the surface of the asbestos fiber, but the production is amplified during phagocytosis of fibers by neutrophils, macrophages, and monocytes (2, 3). We have demonstrated that administration of catalase to wild-type (WT) mice attenuated the development of fibrosis after exposure to asbestos (4), signifying that H2O2 generation by alveolar macrophages is a critical factor in the pathogenesis of asbestosis; however, the source and molecular mechanism of asbestos-induced H2O2 generation in alveolar macrophages is unknown.
H2O2 generation primarily results from dismutation of superoxide anion (O2˙̄), which occurs at a rapid rate (105–106 m−1 s−1) nonenzymatically, and superoxide dismutase (SOD) increases the dismutation reaction by 104-fold (5–7). There are three SOD enzymes: Cu,Zn-SOD (SOD1) is located in the cytosol and mitochondrial intermembrane space (IMS); Mn-SOD (SOD2) is located in the mitochondrial matrix; and EC-SOD (SOD3), which is an extracellular SOD (8, 9).
Alveolar macrophages obtained from patients with pulmonary fibrosis, including asbestosis, have been shown to resemble monocytes (10). These monocytes and young macrophages release ROS, including H2O2, which is associated with the persistent inflammatory response, cell injury, apoptosis, cell proliferation, and fibrogenesis (2, 11, 12). In addition, monocytes have a high level of Cu,Zn-SOD expression, which decreases with cell differentiation (13).
Coupled with our previous observations showing the role of mitochondria in collagen deposition (14), these data demonstrate a novel pathway by which mitochondrial H2O2 generation is augmented by translocation of Cu,Zn-SOD to the IMS in monocytic inflammatory cells. Increased mitochondrial Cu,Zn-SOD expression and activation in monocytic cells induces pulmonary fibrosis by increasing fibroblast collagen production. These results provide a potential target that could protect against the development of a prototypical form of pulmonary fibrosis.
EXPERIMENTAL PROCEDURES
Materials
Chrysotile asbestos was provided by the NAIMA Fiber Repository. p-Hydroxylphenyl acetic acid (pHPA), horseradish peroxidase (HRP), N,N′-dimethyl-9,9′-biacridinium dinitrate (lucigenin reagent), and reduced β-NAD phosphate tetrasodium (NADPH) were purchased from Sigma.
Human Subjects
The Human Subjects Review Board of the University of Iowa Carver College of Medicine approved the protocol of obtaining alveolar macrophages from normal volunteers. Normal volunteers had to meet the following criteria: 1) age between 18 and 55 years; 2) no history of cardiopulmonary disease or other chronic disease; 3) no prescription or nonprescription medication except oral contraceptives; 4) no recent or current evidence of infection; and 5) lifetime nonsmoker. Alveolar macrophages were also obtained from patients with asbestosis. Patients with asbestosis had to meet the following criteria: 1) FEV1 and DLCO at least 60% predicted; 2) current nonsmoker; 3) no recent or current evidence of infection; and 4) evidence of restrictive physiology on pulmonary function tests and interstitial fibrosis on chest computed tomography. Fiber optic bronchoscopy with bronchoalveolar lavage was performed after subjects received intramuscular atropine, 0.6 mg, and local anesthesia. Each subsegment of the lung was lavaged with five 20-ml aliquots of normal saline, and the first aliquot in each was discarded. The percentage of alveolar macrophages was determined by Wright-Giemsa stain and varied from 90 to 98%.
Mice
WT and Cu,Zn-SOD−/− C57BL/6 mice (a generous gift from Dr. Steven Lentz, University of Iowa, Iowa City, IA) were used in these studies, and all protocols were approved by the University of Iowa Institutional Animal Care and Use Committee. Mice were intratracheally administered a dose of 100 μg of chrysotile asbestos suspended in 50 μl of 0.9% saline solution after being anesthetized with 3% isoflurane using a precision Fortec vaporizer (Cyprane, Keighley, UK). One or 21 days after exposure, mice were euthanized with an overdose of isoflurane, and bronchoalveolar lavage (BAL) was performed. BAL cells were used for determination of total and differential cell number, and BAL fluid was used to determine lipid peroxidation. The lungs were removed and stained for collagen fibers using Masson trichrome stain.
Cell Culture
Human monocyte (THP-1), mouse type II alveolar epithelial (MLE-12), and human lung fibroblast (HFL-1) cell lines were obtained from American Type Culture Collection (Manassas, VA). Cells were maintained in RPMI 1640 or DMEM with the following supplements: 2–10% fetal bovine serum and penicillin/streptomycin. All experiments were performed with 0.5% serum supplement.
SOD Activity Assay
SOD activity assays were performed as described previously (15). Briefly, SOD activity was measured by separating samples on a 12% native polyacrylamide gel. The gel was stained by incubation with 2.43 mm nitro blue tetrazolium, 28 μm riboflavin, and 28 mm TEMED in the dark.
Determination of H2O2 Generation
Extracellular H2O2 production was determined using a fluorometric assay as described previously (16). Briefly, cells were incubated in phenol red-free Hanks' balanced salt solution supplemented with 6.5 mm glucose, 1 mm HEPES, 6 mm sodium bicarbonate, 1.6 mm pHPA, and 0.95 μg/ml of HRP. Cells were exposed to chrysotile asbestos and fluorescence of the pHPA dimer was measured using a spectrofluorometer at excitation of 320 nm and emission of 400 nm, respectively.
Isolation of Cytoplasm, Mitochondria, Mitochondrial Intermembrane Space, and Mitoplasts
Cellular compartment separation was performed as described previously (17, 18). The cytoplasm was isolated by suspending cells in 200 μl of lysis buffer (50 mm Tris, pH 8, 10 mm EDTA, protease inhibitor), sonicated for 10 s on ice, and centrifuged at 2,000 × g for 5 min. The supernatant was centrifuged at 100,000 × g for 10 min after which the supernatant containing the cytoplasmic fraction was collected. Mitochondria were isolated by lysing the cells in a mitochondria buffer containing 10 mm Tris, pH 7.8, 0.2 mm EDTA, 320 mm sucrose, and protease inhibitors. Lysates were homogenized using a Kontes Pellet Pestle Motor and centrifuged at 2,000 × g for 8 min at 4 °C. The supernatant was removed and kept at 4 °C, and the pellet was lysed, homogenized, and centrifuged again. The two supernatants were pooled and centrifuged at 12,000 × g for 15 min at 4 °C. The pellet was then resuspended in mitochondria buffer without sucrose. For mitochondrial IMS isolation, the mitochondria fractions were treated with digitonin (0.1 mg of digitonin/mg of mitochondria) for 1 h at room temperature, centrifuged at 10,000 × g for 10 min, and the supernatant was collected. 100 mm Iodoacetamide was added to prevent SOD1 activation while disrupting the outer membrane. For mitoplast isolation, mitochondria were incubated in a 5× volume of cold hypotonic buffer (10 mm Tris, pH 7.4, 1 mm EDTA, and 1 mm dithiothreitol) for 10 min on ice. 150 mm NaCl was added to the buffer for 10 min on ice. Samples were centrifuged at 18,000 × g for 20 min at 4 °C, and then the pellet was resuspended in sucrose-free mitochondria buffer.
Lucigenin Assay
The lucigenin assay was performed with cytosolic or mitochondrial protein (10 μg) as previously described (19).
Plasmids and Transfections
Human Cu,Zn-SOD cDNA (NM_000454) with no stop codon was amplified by PCR and inserted into pcDNA3.1D/V5-His-TOPO vector (Invitrogen). Mutations of cysteines in Cu,Zn-SOD-V5-His were generated using the QuikChange II Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA). The following mutants were generated: Cu,Zn-SOD-V5-HisC57S, Cu,Zn-SOD-V5-HisC146S, and Cu,Zn-SOD-V5-HisC57S,C146S. To generate the Cu,Zn-SOD-GFP construct, SOD1 cDNA with no stop codon was amplified by PCR using a forward primer containing a NheI (underlined) site, 5′-GCT AGC ATG GCG ACG AAG GCC GTG T-3′ and reverse primer having a EcoRV site, 5′-GAT ATC TTG GGC GAT CCC AAT TAC ACC-3′. The resulting PCR product was subcloned into pCR4-TOPO (Invitrogen). The pCR4-SOD construct was digested with NheI and EcoRV and the product was ligated into NheI-EcoRV sites of phMGFP vector (Promega) using T4 DNA ligase. The correct reading frame and sequence of plasmids used in this study were verified by fluorescent automated DNA sequencing performed by the University of Iowa DNA facility. Cells were transfected with vectors by using FuGENE transfection reagent (Roche Applied Science) according to the manufacturer's instructions.
Adenoviral Vectors
THP-1 monocytes were infected with replication-deficient adenovirus type 5 with the E1 region replaced with DNA containing the cytomegalovirus (CMV) promoter region alone (Ad5.CMV) or Ad5.Cu,Zn-SOD vector (Gene Transfer Vector Core, University of Iowa Carver College of Medicine, Iowa City, IA) at a multiplicity of infection of 500 in serum-free RPMI medium. After 5 h, serum was added to the medium to a final concentration of 0.5%, and the cells were allowed to recover for 48 h.
S-Nitrosylation Analysis
5 μg of purified Cu,Zn-SOD protein (Oxis Int. Inc., Portland, OR) was incubated with 1 mm S-nitrosoglutathione (GSNO) (Sigma) for 30 min at room temperature in the dark. Samples then were exposed to 312-nm UV lights for 5 min on ice. Samples were mixed with non-reducing sample buffer and separated by SDS-PAGE.
Immunoblot Analysis
Whole cells lysates were obtained as previously described (20) and separated by SDS-PAGE. Immunoblot analyses were performed with the designated antibodies followed by the appropriate secondary antibody cross-linked to HRP.
Confocal Microscopy
THP-1 cells were transfected with phMGFP-SOD vector in a coverglass chamber and allowed to recover for 24 h. After exposing to chrysotile asbestos for 3 h, medium was changed to Hanks' balanced salt solution containing 500 nm MitoTracker Red (Molecular Probes, Eugene, OR) and incubated for 30 min at 37 °C. The 488- and 579-nm lines of a krypton/agron laser were used for measuring the fluorescence excitation of GFP and MitoTracker Red, respectively.
Small Interfering RNA (siRNA)
THP-1 cells were transfected with 100 nm scrambled (Santa Cruz Biotechnology, Santa Cruz, CA), human Rieske, or Cu,Zn-SOD siRNA duplex (IDT, Iowa City, IA) using DharmaFect 2 reagent (Dharmacon Research, Lafayette, CO) or together with Cu,Zn-SOD-V5-His or empty vector by using DharmaFect Duo reagent in antibiotic- and serum-free media, according to the manufacturer's instructions. After 4 h, serum was added to a final concentration of 10%, and the cells were allowed to recover for 72 h.
Quantitative Real Time PCR
Total RNA from homogenized lungs or isolated BAL cells were obtained using TRIzol reagent (Sigma). After reverse transcription using the iScript reverse transcription kit (Bio-Rad), collagen Ia1, TGF-β, and HPRT mRNA expression were determined by quantitative real time PCR using SYBR Green kit (Bio-Rad) on an IQ5 Real-time PCR machine (Bio-Rad). The following primer sets were used: collagen Ia1, 5′-GAG TTT CCG TGC CTG GCC CC-3′ and 5′-ACC TCG GGG ACC CAT CTG GC-3′; TGF-β, 5′-CGG AGA GCC CTG GAT ACC A-3′ and 5′-TGC CGC ACA CAG CAG TTC-3′; and HPRT, 5′-CCT CAT GGA CTG ATT ATG GAC-3′ and 5′-CAG ATT CAA CTT GCG CTC ATC-3′. Data were calculated by the ΔΔCT method. Collagen I and TGF-β mRNA were normalized to HPRT and are expressed as arbitrary units.
ELISA
Active TGF-β in cell medium was measured by using a TGF-β ELISA kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Lipid Peroxidation
Lipid peroxidation in BAL fluid was measured by using a thiobarbituric acid reactive substance kit (Cayman, Ann Arbor, MI) according to the manufacturer's instructions.
Glutathione Assay
Lung tissue that had been perfused to remove red blood cells was homogenized directly into 5-sulfosalicylic acid (5% w/v), centrifuged, and the supernatant saved at −80 °C overnight for the glutathione assay. The protein pellet was dissolved in NaOH and the protein concentration was determined. Total glutathione content was determined as described (21). Reduced glutathione (GSH) and glutathione disulfide (GSSG) were distinguished by addition of 20 μl of a 1:1 mixture of 2-vinylpyridine and ethanol per 100 μl of sample, followed by incubation for 2 h and assayed as described previously (22). All glutathione determinations were normalized to the protein content of the lung homogenates.
Statistical Analysis
Statistical comparisons were performed using an unpaired, one-tailed t test. Values in the figures are expressed as mean ± S.E. and p < 0.05 was considered significant.
RESULTS
Alveolar Macrophages Obtained from Patients with Asbestosis Generate High Levels of H2O2 and Have Increased Expression and Activity of Cu,Zn-SOD
Alveolar macrophages obtained from the lungs of patients with pulmonary fibrosis are known to generate ROS, including H2O2 (23). To confirm that this phenomenon occurred in patients with asbestosis, we obtained alveolar macrophages from normal subjects and patients with asbestosis. We found that alveolar macrophages obtained from asbestosis patients had 10-fold greater rate of spontaneous H2O2 generation compared with normal subjects (Fig. 1A).
FIGURE 1.
Asbestos patients have high levels of H2O2 and increased expression and activity of Cu,Zn-SOD in alveolar macrophages. A, alveolar macrophages from asbestosis patients and normal volunteers were incubated in Hanks' balanced salt solution supplemented with pHPA and HRP. H2O2 concentrations were measured spectrofluorometrically. *, p < 0.05 versus normal subjects (n = 6 per each group). B, SOD expression from asbestosis patients (n = 3) and normal subjects (n = 4) were measured by immunoblot analysis. C, Mn-SOD activity; and D, Cu,Zn-SOD activity were measured by native gel with nitro blue tetrazolium staining and expressed as densitometry; *, p < 0.05 versus normal subjects.
SOD increases H2O2 generation 104-fold from the dismutation of O2˙̄ compared with spontaneous dismutation, so we next determined if there was a difference in SOD expression and activity between patients and normal subjects. Whole cell lysates were separated by SDS-PAGE to determine SOD expression or by native gel to determine SOD activity. We found that alveolar macrophages obtained from asbestosis patients had similar Mn-SOD expression (Fig. 1B) and activity compared with the normal subjects (Fig. 1C). In contrast, the asbestosis patients had significantly more Cu,Zn-SOD expression and Cu,Zn-SOD activity than normal subjects (Fig. 1, B and D). Based on these results, we formulated the hypothesis that Cu,Zn-SOD is the primary determinant for increasing production of H2O2 in asbestosis patients.
Cu,Zn-SOD in the Mitochondrial IMS Contributed to H2O2 Production
To determine whether Cu,Zn-SOD was important in increasing H2O2, we overexpressed Cu,Zn-SOD and measured H2O2 generation. THP-1 monocytes were infected with a replicative-deficient adenovirus containing either an empty vector (Ad5.CMV) or Cu,Zn-SOD (Ad5.Cu,Zn-SOD). Extracellular H2O2 concentration was significantly increased in cells infected with Ad5.Cu,Zn-SOD compared with Ad5.CMV-infected cells (Fig. 2A). Due to the fact that Cu,Zn-SOD is known to be located in the cytoplasm and in the mitochondrial IMS, we isolated each cell compartment and performed an immunoblot analysis for Cu,Zn-SOD. Cu,Zn-SOD was distributed in both mitochondria and cytoplasm. In mitochondria, Cu,Zn-SOD was concentrated in the IMS (Fig. 2B).
FIGURE 2.
Cu,Zn-SOD in the mitochondrial intermembrane spaces contributes to the increased level of H2O2 production. A, THP-1 monocytes were infected with a replication-deficient adenovirus vector expressing either an empty vector (Ad5.CMV) or Cu,Zn-SOD vector (Ad5.Cu,Zn-SOD) for 48 h. Extracellular H2O2 levels were measured by applying the pHPA method, n = 4, *, p < 0.05 Ad5.CMV versus Ad5.Cu,Zn-SOD. B, different cellular fractions were isolated and immunoblot analysis for Cu,Zn-SOD was performed. In mitochondria, Cu,Zn-SOD is localized in the intermembrane space. C, THP-1 monocytes were transfected with either an empty vector or pcDNA3.1Cu,Zn-SOD-V5-His vector. After 24 h, 10 μg of mitochondrial (mito) and cytoplasmic (cyto) protein lysates were used for measuring superoxide anion generation utilizing lucigenin assay. n = 3, *, p < 0.05, empty versus Cu,Zn-SOD-V5-His. D, superoxide anion generation expressed as relative light units (RLU)/min. n = 4, *, p < 0.05 versus empty vector.
Because we found Cu,Zn-SOD expression in different cellular fractions, we next determined the site and effect of Cu,Zn-SOD overexpression on O2˙̄ generation. Cells were transfected with either an empty vector or Cu,Zn-SOD-V5-His, and cytoplasmic and mitochondrial fractions were isolated. O2˙̄ generation progressively increased in the mitochondrial fraction, and overexpression of Cu,Zn-SOD-V5-His significantly inhibited the generation (Fig. 2C). In contrast, minimal O2˙̄ was generated in the cytoplasm, and overexpression of Cu,Zn-SOD-V5-His had no effect on cytoplasmic O2˙̄ levels. Overexpression of Cu,Zn-SOD also reduced the rate of mitochondrial O2˙̄ generation (Fig. 2D). In aggregate, these data demonstrate that Cu,Zn-SOD is highly expressed in the mitochondria of monocytes, and it enhances the dismutation of O2˙̄ to H2O2.
Asbestos Induced the Translocation and Activation of Cu,Zn-SOD in the IMS of Mitochondria
To further address the role of Cu,Zn-SOD in mitochondria after asbestos exposure, THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His vector and exposed to chrysotile for 3 h. Mitochondrial fractions were isolated and an immunoblot assay was performed for the tagged protein. Cu,Zn-SOD-V5-His increased dramatically in the mitochondria obtained from cells exposed to asbestos (Fig. 3A). The observation of translocation was confirmed with confocal microscopy (Fig. 3B). Cells were transfected with phMGFP-SOD vector. After 24 h, cells were exposed to chrysotile asbestos for 3 h, and MitoTracker Red was used to stain the mitochondria. In the absence of asbestos, the GFP expression had a diffuse distribution (upper left panel), whereas MitoTracker Red distinguished the mitochondria (upper middle panel). The merged image of GFP and MitoTracker Red (Fig. 3B, upper right panel) demonstrated that there was no aggregation of the Cu,Zn-SOD in the mitochondria. In contrast, in cells exposed to chrysotile for 3 h, GFP (bottom left panel) was concentrated in the mitochondria as seen with MitoTracker Red (bottom middle panel), and the merged panel demonstrated that Cu,Zn-SOD localized to the mitochondria (Fig. 3B, bottom right panel).
FIGURE 3.
Asbestos induced translocation of Cu,Zn-SOD in the mitochondrial IMS. A, THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His vector for 24 h and then incubated in the presence or absence of chrysotile asbestos. Mitochondrial fractions were isolated and immunoblot analysis was performed for V5. B, THP-1 monocytes were transfected with phMGFP-Cu,Zn-SOD vector for 24 h and then incubated in the presence or absence of chrysotile asbestos. Cells were then suspended in Hanks' balanced salt solution with 500 nm MitoTracker Red at 37 °C for 30 min and confocal microscopy was performed. C, MLE-12 alveolar type II epithelial cells were transfected with Cu,Zn-SOD-V5-His vector for 24 h and then incubated in the presence or absence of chrysotile. Mitochondrial fractions were isolated and immunoblot analysis was performed for V5. D, THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His mutants (C57S, C146S, or C57S,C146S). Mitochondrial fractions were isolated and immunoblot analysis was performed for V5. E, THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His mutants (C57S, C146S, or C57S,C146S) for 24 h and then exposed to chrysotile asbestos. Cytoplasmic fractions were isolated and separated by SDS-PAGE. Exposure to chrysotile asbestos was 3 h in A–E.
Alveolar epithelial cells are known to generate mitochondrial ROS after exposure to asbestos and other environmental toxins (24, 25), so we questioned whether asbestos increased translocation of Cu,Zn-SOD in epithelial cells. MLE-12 cells were transfected with the Cu,Zn-SOD-V5-His vector. After 24 h the cells were exposed to chrysotile for 3 h, and mitochondrial fractions were isolated. An immunoblot for the tagged protein demonstrated that Cu,Zn-SOD levels in mitochondria decreased after asbestos exposure (Fig. 3C), suggesting that the phenomenon of Cu,Zn-SOD translocation is unique to monocytes.
Only apo-Cu,Zn-SOD, an immature and inactive form, translocates to mitochondria (26). The import of proteins, such as Cox17 and TIM13 (translocase of the inner membrane), into the IMS requires the presence of conserved cysteine motifs (27). Cysteine 57 and cysteine 146 comprise the conserved cysteine motif in Cu,Zn-SOD that form an intramolecular disulfide bond (28). To determine whether the cysteines involved in forming the disulfide bond in Cu,Zn-SOD have a role in translocation, we generated Cu,Zn-SOD constructs with mutations in either cysteine 57 (Cu,Zn-SOD-V5-HisC57S) or cysteine 146 (Cu,Zn-SOD-V5-HisC146S) and a construct containing mutations in both cysteine residues (Cu,Zn-SOD-V5-HisC57S,C146S). THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His mutants and exposed to chrysotile asbestos for 3 h. Mitochondrial fractions were isolated and an immunoblot assay was performed for the tagged protein. The single cysteine mutations in Cu,Zn-SOD did not alter translocation to the IMS, but the construct containing mutations in both cysteines was not detected in the IMS in either the presence or absence of asbestos (Fig. 3D).
Because the Cu,Zn-SOD-V5-HisC57S,C146S was not imported to the IMS, we determined whether it was stably expressed in the cytoplasmic compartment. Cells were transfected with mutant Cu,Zn-SOD expression vectors. After 24 h, cytoplasmic fractions were isolated, and an immunoblot assay was performed for the tagged protein. The C57S and C146S mutants had much lower cytoplasmic expression compared with the C57S,C146S mutant (Fig. 3E). This observation confirms that Cu,Zn-SOD-V5-HisC57S,C146S is stably expressed and is retained in the cytoplasm. In aggregate, these data demonstrate that asbestos exposure induces translocation of Cu,Zn-SOD to the IMS in monocytes, and translocation requires the presence of at least one conserved cysteine residue.
Translocation and Activation of Cu,Zn-SOD Was Redox Sensitive
The formation of the disulfide bond between cysteine 57 and cysteine 146 is necessary for activation of Cu,Zn-SOD (28). To determine whether the Cu,Zn-SOD was active in the mitochondria after asbestos exposure, THP-1 monocytes were exposed to chrysotile for 3 h. Mitochondria were isolated, and samples were separated on a polyacrylamide gel in the presence or absence of β-ME, which reduces the disulfide bonds. Cells exposed to asbestos for 3 h had an increase in disulfide-linked Cu,Zn-SOD, whereas this activated form was significantly reduced with β-ME (Fig. 4A). To further confirm that Cu,Zn-SOD was active in the IMS, THP-1 monocytes were exposed to asbestos for 3 h, and mitochondrial fractions were isolated. The mitochondrial fractions isolated from cells exposed to asbestos had a significantly higher level of H2O2 production compared with mitochondria obtained from non-exposed cells (Fig. 4B).
FIGURE 4.
Mitochondrial Cu,Zn-SOD activation requires conserved cysteines. A, THP-1 monocytes were incubated with or without chrysotile asbestos for 3 h and mitochondrial fractions were isolated and separated by SDS-PAGE in the absence or presence of β-ME. Ox = activated (oxidized) disulfide bond-linked Cu,Zn-SOD; Red = reduced Cu,Zn-SOD monomer. B, mitochondrial fractions were isolated and a pHPA assay was performed. n = 4, *, p < 0.05 control versus chrysotile asbestos. C, 5 μg of purified Cu,Zn-SOD was incubated with 1 mm GSNO and then exposed to UV for 5 min or 10 mm DTT. Immunoblot analysis was performed for Cu,Zn-SOD and S-nitrosocysteine. D, THP-1 monocytes were transfected with Cu,Zn-SOD-V5-His mutants (C57S, C146S, and C57S,C146S) for 24 h and then incubated with chrysotile asbestos for 3 h. Mitochondrial fractions of cells transfected with C57S and C146S mutants and cytoplasmic fractions of cells transfected with C57S,C146S mutants were isolated and separated by SDS-PAGE with or without 10 mm DTT. Ox = activated (oxidized) disulfide bond-linked Cu,Zn-SOD; Red = reduced Cu,Zn-SOD monomer. E, THP-1 monocytes were transfected with an empty vector, Cu,Zn-SOD-V5-His (WT), or Cu,Zn-SOD-V5-His mutants for 24 h and then exposed to chrysotile asbestos for 3 h. H2O2 generation was measured with pHPA assay. n = 4, *, p < 0.05 wild type versus empty; **, p < 0.05 wild type versus C57S, C146S, or C57S,C146S.
In addition to oxidation, another post-translational modification of proteins containing cysteine residues is S-nitrosylation, which is known to influence multimer formation and signal transduction (29–31). To determine whether Cu,Zn-SOD was modified in this manner, purified Cu,Zn-SOD was incubated in the presence or absence of the NO donor GSNO. The Cu,Zn-SOD monomer was S-nitrosylated when incubated with GSNO, but it inhibited Cu,Zn-SOD multimer formation. Multimer formation was increased when the S-nitrosylated Cu,Zn-SOD was exposed to ultraviolet radiation (UV), which results in photolysis of the S-nitrosocysteine (Fig. 4C).
Because a conserved cysteine motif is necessary for translocation of Cu,Zn-SOD to the mitochondria, we determined the effect of cysteine mutations on the ability to form active multimers. THP-1 cells were transfected with the cysteine mutants (C57S, C146S, or C57S,C146S). After 24 h, cells were exposed to chrysotile asbestos. Mitochondrial fractions were isolated for the cells expressing C57S or C146S, and cytoplasmic fractions were isolated for cells expressing C57S,C146S. Samples were separated on a polyacrylamide gel in the presence or absence of the reducing agent DTT. We observed that none of the cysteine mutants formed multimers (Fig. 4D).
To determine whether Cu,Zn-SOD translocation is linked to mitochondrial H2O2 generation, we transfected THP-1 monocytes with an empty vector, Cu,Zn-SOD-V5-His (WT) or the cysteine mutants (C57S, C146S, or C57S,C146S). After 24 h, cells were exposed to chrysotile asbestos for 3 h. H2O2 generation in cells expressing the WT Cu,Zn-SOD was significantly higher than cells expressing the empty vector (Fig. 4E). Cells expressing either one of the single mutants (C57S, C146S), which are not able to form an active multimer, had a significant reduction in H2O2 generation to near control levels. Cells expressing C57S,C146S had a similar reduction in H2O2 generation compared with cells expressing the WT Cu,Zn-SOD (Fig. 4E). Taken together, these data demonstrate that asbestos-induced translocation of Cu,Zn-SOD to the IMS requires at least one of the conserved cysteine residues; however, both cysteine residues are necessary for multimer formation, enzyme activation, and subsequent H2O2 generation after exposure to asbestos.
The mitochondrial electron transport chain (ETC) is a major site of O2˙̄ production in both quiescent and activated cells. Because Cu,Zn-SOD translocation required a conserved cysteine motif and cysteines are targets of oxidation, we questioned whether increased mitochondrial ROS generation after asbestos exposure regulated translocation. THP-1 monocytes were transfected with the empty or Cu,Zn-SOD-V5-His vector in combination with either scrambled or Rieske siRNA to determine the effect on H2O2 generation as a function of Cu,Zn-SOD activity. Rieske is the iron-sulfur protein component of the cytochrome bc1 complex (complex III). Overexpression of Cu,Zn-SOD increased H2O2 production in cells transfected with either Cu,Zn-SOD-V5-His alone or with the scrambled siRNA (Fig. 5A). In contrast, cells transfected with the Rieske siRNA had a significant inhibition of H2O2. Overexpression of Cu,Zn-SOD in cells expressing the Rieske siRNA resulted in marked inhibition of H2O2 generation compared with cells expressing the empty vector alone (Fig. 5A). Rieske knockdown also significantly abrogated the rate of H2O2 generation (Fig. 5B). These data demonstrate that knockdown of complex III inhibited the production of H2O2 after asbestos exposure. In addition, Cu,Zn-SOD-induced H2O2 generation after asbestos exposure required an active complex III.
FIGURE 5.
Translocation and activation of Cu,Zn-SOD is redox sensitive. A, THP-1 monocytes were transfected with either Rieske siRNA or a scrambled siRNA together with either an empty or Cu,Zn-SOD-V5-His vector for 72 h and then exposed to chrysotile asbestos. H2O2 generation was measured utilizing the pHPA method. B, rate of H2O2 generation expressed as nanomoles/106 cells/min. n = 3, *, p < 0.01 versus empty; **, p < 0.01 versus empty. C, THP-1 monocytes were transfected with either Rieske siRNA or a scrambled siRNA for 72 h and then incubated with chrysotile asbestos for 3 h. The mitochondrial fraction was isolated and separated by SDS-PAGE with or without β-ME. Ox = activated (oxidized) disulfide bond-linked Cu,Zn-SOD; Red = reduced Cu,Zn-SOD monomer.
To confirm that the mitochondrial-derived ROS was required for mitochondrial Cu,Zn-SOD translocation and activation, THP-1 monocytes were transfected with scrambled or Rieske siRNA. After 72 h, cells were exposed to chrysotile asbestos for 3 h. Mitochondrial fractions were isolated and separated on a polyacrylamide gel in the presence or absence of β-ME. In the presence of β-ME, the disulfide bond-linked Cu,Zn-SOD was not present. In the absence of β-ME, cells expressing the scrambled siRNA had the activated, disulfide bond linked in Cu,Zn-SOD. In contrast, cells expressing the Rieske siRNA had a significant reduction in the activated Cu,Zn-SOD in the mitochondria (Fig. 5C). In aggregate, these data demonstrate that Cu,Zn-SOD-mediated H2O2 generation is strikingly reduced with knockdown of a critical redox center of complex III. These data also show that translocation and activation the Cu,Zn-SOD in the IMS are coupled to the activity of mitochondrial ETC.
Cu,Zn-SOD Regulates Asbestos-induced Oxidative Stress in Vivo
To better define the potential biological relevance of Cu,Zn-SOD in the pathogenesis of pulmonary fibrosis, we exposed WT and Cu,Zn-SOD−/− C57BL/6 mice to chrysotile asbestos. The predominant cells seen in the BAL fluid at 21 days were alveolar macrophages (data not shown). To demonstrate that Cu,Zn-SOD had a role in the generation of H2O2 in vivo after asbestos exposure, we isolated monocytes and macrophages from bone marrow from WT and Cu,Zn-SOD−/− mice. Cells were cultured in the presence or absence of asbestos, and H2O2 generation was measured. Cells taken from WT animals demonstrated significantly higher production of H2O2 when compared with cells obtained from Cu,Zn-SOD−/− mice. H2O2 generation was also significantly enhanced in cells from WT mice after asbestos exposure (Fig. 6A). In contrast, asbestos exposure had no effect on H2O2 production in Cu,Zn-SOD−/− monocytes/macrophages indicating that Cu,Zn-SOD is crucial for the H2O2 generation after asbestos exposure in vivo (Fig. 6B).
FIGURE 6.
Cu,Zn-SOD modulates asbestos-induced oxidative stress in vivo. A, macrophages and monocytes were isolated from WT mice (n = 7) and Cu,Zn-SOD−/− mice (n = 7) bone marrow. Cells were cultured in the presence or absence of chrysotile asbestos. H2O2 generation was measured by pHPA assay. B, rate of hydrogen peroxide generation expressed in nanomoles/106 cells/min. *, p < 0.05 versus Cu,Zn-SOD−/− control; **, p < 0.01 versus Cu,Zn-SOD−/− mice exposed to chrysotile asbestos. C, WT mice and Cu,Zn-SOD−/− mice were exposed to 100 μg of chrysotile asbestos intratracheally. Animals were euthanized after 21 days, and BAL fluid was obtained. Oxidized lipid is expressed as micromolar malondialdehyde (MDA)/μg of protein in BAL fluid. WT (n = 4) and Cu,Zn-SOD−/− (n = 4); *, p < 0.01 versus WT mice. D, mice were exposed to chrysotile asbestos as in C. After 21 days the mice were euthanized and lungs were removed and homogenized for glutathione assay. Total GSH in disulfide form was expressed as % GSH as GSSG WT (n = 3) and Cu,Zn-SOD−/− (n = 3); *, p < 0.02 versus WT.
Due to the significant differences in H2O2 levels between WT and Cu,Zn-SOD−/− cells, we questioned whether Cu,Zn-SOD had a role in mediating increases in parameters indicative of oxidative stress in the lungs after asbestos exposure. Unsaturated lipids are significant components of surfactant and have been suggested to be major targets for lipid peroxidation during inflammation and lung injury (32). WT and Cu,Zn-SOD−/− mice were exposed to chrysotile asbestos, and lipid peroxidation was determined at 21 days utilizing the thiobarbituric acid reactive substances assay. WT mice had greater than 6-fold higher levels of lipid peroxidation in BAL fluid compared with Cu,Zn-SOD−/− mice (Fig. 6C). In addition, when lung tissue from similarly treated animals was assayed for the percentage of total glutathione (GSH) in the disulfide form (% GSSG), which signifies an increase in oxidation of GSH, the lungs from WT mice again demonstrated significantly higher % GSSG relative to the Cu,Zn-SOD−/− (Fig. 6D).
Taken together, these data are completely consistent with the hypothesis that monocyte/macrophages from the lungs of WT mice exposed to asbestos have significantly greater H2O2 production, which resulted in increased oxidative stress in both the BAL fluid and lung parenchyma. Furthermore, given that asbestos induced high levels of H2O2 and that the levels of oxidative stress detected in the lungs were reduced in the lungs of Cu,Zn-SOD−/− mice strongly supports the conclusion that Cu,Zn-SOD was a significant source of H2O2 following exposure to asbestos.
Cu,Zn-SOD−/− Mice Were Protected from Developing Pulmonary Fibrosis After Asbestos Exposure
To determine whether the relationship between Cu,Zn-SOD and H2O2 generation and oxidative stress in the lung had an effect on the development of pulmonary fibrosis, WT and Cu,Zn-SOD−/− mice were exposed to chrysotile asbestos. After 21 days, the animals were euthanized and lungs were excised and processed for staining with Masson trichrome to visualize collagen deposition. The lungs of WT mice had widespread collagen deposition in both peribronchial and parenchymal portions of the lung (Fig. 7A). In contrast, the collagen deposition in Cu,Zn-SOD−/− mice was significantly attenuated (Fig. 7B).
FIGURE 7.
Cu,Zn-SOD−/− mice were protected from developing pulmonary fibrosis after asbestos exposure. A, WT and B, Cu,Zn-SOD−/− mice were exposed to 100 μg of chrysotile asbestos intratracheally. 21 days later the animals were euthanized and lungs were removed and processed for collagen deposition using Masson trichome staining. WT mice have peribronchial and parenchymal collagen deposition compared with Cu,Zn-SOD−/− mice. Representative micrographs of 1 of 7 animals are shown. Bar indicates 200 μm. C, total RNA was obtained from lung homogenates of mice exposed to chrysotile asbestos (100 μg). Results show arbitrary units of collagen I mRNA normalized to HPRT mRNA. Cu,Zn-SOD−/− (n = 6) and WT (n = 4). *, p < 0.01 versus WT mice. Inset, whole lung homogenates from WT (n = 2) and Cu,Zn-SOD−/− (n = 2) mice were separated by SDS-PAGE and immunoblot analysis for Mn-SOD and Cu,Zn-SOD was performed. D, THP-1 cells were infected with either Ad5.CMV or Ad5.Cu,Zn-SOD. After 48 h, cell supernatants were collected and ELISA was performed, n = 2, *, p < 0.013. E, mice were exposed to chrysotile asbestos (100 μg) as in A. 1 day later the animals were euthanized and BAL was performed. BAL cells were collected, and total RNA was obtained. Results show arbitrary units of TGF-β mRNA normalized to HPRT mRNA. n = 3 per strain. F, THP-1 cells were transfected with either a scrambled or Cu,Zn-SOD siRNA (100 nm). After 72 h, conditioned medium was removed and placed on HLF-1 cells. HLF-1 cells were cultured for 24 h in the presence or absence of chrysotile asbestos. Procollagen I and collagen I in the medium was determined by immunoblot analysis.
To verify the histopathological observations, we determined the extent of pulmonary fibrosis biochemically. Total mRNA was isolated from homogenized lungs obtained from mice 21 days after asbestos exposure. Collagen Ia1 mRNA expression was greater than 5-fold higher in the lungs of WT mice compared with Cu,Zn-SOD−/− mice (Fig. 7C).
Because TGF-β is a pro-fibrotic cytokine produced by macrophages, we determined the role of Cu,Zn-SOD in regulating its expression in vitro and in vivo. THP-1 monocytes were infected with a replicative-deficient adenovirus containing either an empty vector or Cu,Zn-SOD. After 48 h the supernatants were harvested, and active TGF-β was determined by ELISA. Cells expressing Cu,Zn-SOD produced significantly more active TGF-β than cells expressing the empty vector (Fig. 7D). In WT and Cu,Zn-SOD−/− mice exposed to asbestos, BAL cells were obtained and TGF-β mRNA expression was quantified. Cells collected from asbestos-exposed WT mice expressed greater than 4-fold more TGF-β mRNA compared with Cu,Zn-SOD−/− mice (Fig. 7E). These data suggest that mitochondrial Cu,Zn-SOD regulates TGF-β production in macrophages.
Because fibroblasts are the primary cell that produces collagen and to provide a direct link between Cu,Zn-SOD and pulmonary fibrosis, we transfected THP-1 macrophages with either a scrambled or Cu,Zn-SOD siRNA. After 72 h, the conditioned medium was collected. Human lung fibroblasts (HLF-1) were cultured for 24 h in the conditioned medium obtained from the transfected cells in the presence or absence of chrysotile asbestos. The conditioned medium from the fibroblast cultures was used to measure collagen I secretion. HLF-1 cells exposed to conditioned medium from THP-1 cells transfected with the scrambled siRNA had significantly more procollagen I and collagen I compared with cells exposed to the conditioned medium from the Cu,Zn-SOD siRNA-transfected cells (Fig. 7F). Taken together, these data demonstrate that the antioxidant enzyme Cu,Zn-SOD induces pulmonary fibrosis via translocation and activation in the mitochondrial IMS where it enhances the generation of H2O2.
DISCUSSION
Although H2O2 generation has been linked to pulmonary fibrosis, little is known about its source or mechanism of production. In this study, we demonstrate that Cu,Zn-SOD translocation and activation in the IMS is unique to monocytes and macrophages and is dependent on a conserved cysteine motif and mitochondrial ETC function. These data also demonstrate that H2O2 generation is regulated by the presence of Cu,Zn-SOD in the IMS, which, in part, modulates the development of pulmonary fibrosis after asbestos exposure. Evidence to support this pathway include (i) asbestos increased mitochondrial ROS generation and increases translocation of Cu,Zn-SOD to the IMS; (ii) a conserved cysteine motif was necessary for translocation and activation; (iii) knockdown of the iron-sulfur protein, Rieske, decreased Cu,Zn-SOD translocation and activation; (iv) mitochondrial H2O2 generation is dependent on complex III O2˙̄ generation as knockdown of Rieske inhibited H2O2 production by Cu,Zn-SOD; (v) Cu,Zn-SOD−/− mice had reduced H2O2 generation, decreased oxidative stress in the BAL fluid and the lung parenchyma, and were protected from developing pulmonary fibrosis; and (vi) knockdown of Cu,Zn-SOD in monocytes inhibits collagen I deposition by lung fibroblasts. Taken together, these observations provide novel insight into the mechanism linking H2O2 generation to pulmonary fibrosis and delineate the role of Cu,Zn-SOD in regulating mitochondrial H2O2 production.
We have shown that mitochondrial H2O2 production promotes the development of asbestos-induced pulmonary fibrosis by increasing collagen production in fibroblasts, and intratracheal administration of catalase attenuates asbestos-induced pulmonary fibrosis (4, 14). The use of other antioxidant enzymes, such as PEG-SOD, have not been effective in preventing pulmonary fibrosis (33). It is unclear in this study, however, if PEG-SOD exacerbated the lung injury. Moreover, the effect of SOD on the development of pulmonary fibrosis is not known.
Alveolar macrophages obtained from the lung of patients with chronic lung disease, such as pulmonary fibrosis, are known to resemble monocytes (10, 34). This is likely secondary to persistent recruitment of monocytes to the site of injury. Cu,Zn-SOD is highly expressed in monocytes, and the expression decreases with differentiation to mature macrophages (13). Studies have shown Mn-SOD to be increased in animal models after exposure to asbestos (35, 36), whereas Cu,Zn-SOD expression was not altered with asbestos exposure. These studies, however, measured expression in whole lung homogenates, whereas we have focused on the role of inflammatory cells in the pathogenesis of pulmonary fibrosis. Our data suggest a new conceptual framework for understanding asbestosis, and potentially other forms of pulmonary fibrosis, in that the increased Cu,Zn-SOD in the alveolar macrophages from asbestosis patients is secondary to the presence of monocytes and young macrophages in the lung.
An observation in our study regarding the mechanism of Cu,Zn-SOD-mediated H2O2 generation is that asbestos triggers translocation of Cu,Zn-SOD into the IMS, and this translocation was regulated by the presence of at least one cysteine in the conserved cysteine motif and mitochondrial ETC ROS production. Only apo-Cu,Zn-SOD, an immature and inactive form, translocates to mitochondria (26). Activation of apo-Cu,Zn-SOD requires insertion of copper and zinc and the formation of an intramolecular disulfide bond between cysteine 57 and cysteine 146. Although the mechanism of zinc insertion remains unknown, the copper chaperone for SOD1 (CCS) controls the insertion of copper, which is also necessary to activate Cu,Zn-SOD (9). However, in mammalian cells, a CCS-independent copper insertion and Cu,Zn-SOD activation pathway also exists (37). We found that there was no alteration of CCS in the mitochondria in cells exposed to asbestos (data not shown), suggesting activation of Cu,Zn-SOD was CCS-independent.
Intramolecular disulfide bond formation between the thiol groups of the Cu,Zn-SOD monomer is also necessary for the activation of Cu,Zn-SOD (38), and our data demonstrate that disulfide bond formation is regulated by the redox environment of the IMS. Complex III is the major ROS production site among all mitochondrial ETC complexes, and it is the only complex that generates O2˙̄ in the IMS (39). The Rieske protein is one of the four redox centers in complex III that plays an important role of transferring electrons from ubiquinol in cytochrome b to the heme group in cytochrome c1. Inhibition of Rieske protein by myxothiazol has been shown to reduce the extracellular H2O2 level in intact heart mitochondria (40). Our data, however, demonstrate that knockdown of the Rieske protein inhibits Cu,Zn-SOD translocation and activation, which underscores a critical functional role of the mitochondrial ETC and redox environment for Cu,Zn-SOD uptake and subsequent activation in the IMS. In addition, although at least one of the conserved cysteine residues is required for translocation, both Cys-57 and Cys-146 are necessary for Cu,Zn-SOD activation.
Other disorders, such as Down syndrome and amyotrophic lateral sclerosis, which have either increased or altered Cu,Zn-SOD activity, exhibit oxidative stress that is linked to disease development (41, 42). Our data demonstrate that WT mice have greater lipid peroxidation in BAL fluid and oxidized GSH in lung tissue than Cu,Zn-SOD−/− mice, suggesting H2O2 generated by Cu,Zn-SOD results in increased oxidative stress in the lung. Our data demonstrate that decreased mitochondrial H2O2 generation results in decreased collagen deposition and supports our notion that Cu,Zn-SOD-mediated H2O2 generation is, in part, responsible for the development of pulmonary fibrosis after exposure to asbestos. These observations provide a potential target that could protect against the development of a prototypical form of pulmonary fibrosis.
Acknowledgments
We thank Thomas Moninger and the Central Microscopy Research Facilities at the University of Iowa for assistance with confocal microscopy and Andrea Adamcakova-Dodd, Sarah Perry, and Peter Thorne at the University of Iowa College of Public Health for assistance in animal exposures.
This work was supported, in whole or in part, by National Institutes of Health Grants ES015981, ES014871 (to A. B. C.), and P30 CA086862 (to University of Iowa Cancer Center).
- ROS
- reactive oxygen species
- SOD
- superoxide dismutase
- IMS
- intermembrane space
- pHPA
- p-hydroxylphenyl acetic acid
- TEMED
- N,N,N′,N′-tetramethylethylenediamine
- GSNO
- S-nitrosoglutathione
- ETC
- electron transport chain
- HPRT
- hypoxanthine-guanine phosphoribosyltransferase
- BAL
- bronchoalveolar lavage
- β-ME
- β-mercaptoethanol
- VDAC
- voltage-dependent anion channel.
REFERENCES
- 1. Attfield M. D., Wood J. M., Antao V. C., Pinheiro G. A. (2004) MMWR Morb. Mortal. Wkly. Rep. 53, 627–63215269698 [Google Scholar]
- 2. Kamp D. W., Weitzman S. A. (1999) Thorax 54, 638–652 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Mossman B. T., Marsh J. P. (1989) Environ. Health Perspect. 81, 91–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Murthy S., Adamcakova-Dodd A., Perry S. S., Tephly L. A., Keller R. M., Metwali N., Meyerholz D. K., Wang Y., Glogauer M., Thorne P. S., Carter A. B. (2009) Am. J. Physiol. Lung Cell Mol. Physiol. 297, L846–855 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. McCord J. M., Fridovich I. (1969) J. Biol. Chem. 244, 6049–6055 [PubMed] [Google Scholar]
- 6. Fridovich I. (1986) Adv. Enzymol. Relat. Areas Mol. Biol. 58, 61–97 [DOI] [PubMed] [Google Scholar]
- 7. Fridovich I., Freeman B. (1986) Annu. Rev. Physiol. 48, 693–702 [DOI] [PubMed] [Google Scholar]
- 8. Okado-Matsumoto A., Fridovich I. (2001) J. Biol. Chem. 276, 38388–38393 [DOI] [PubMed] [Google Scholar]
- 9. Sturtz L. A., Diekert K., Jensen L. T., Lill R., Culotta V. C. (2001) J. Biol. Chem. 276, 38084–38089 [DOI] [PubMed] [Google Scholar]
- 10. Hance A. J., Douches S., Winchester R. J., Ferrans V. J., Crystal R. G. (1985) J. Immunol. 134, 284–292 [PubMed] [Google Scholar]
- 11. Bitterman P. B., Wewers M. D., Rennard S. I., Adelberg S., Crystal R. G. (1986) J. Clin. Invest. 77, 700–708 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Carter A. B., Tephly L. A., Venkataraman S., Oberley L. W., Zhang Y., Buettner G. R., Spitz D. R., Hunninghake G. W. (2004) Am. J. Respir. Cell Mol. Biol. 31, 43–53 [DOI] [PubMed] [Google Scholar]
- 13. Auwerx J. H., Chait A., Wolfbauer G., Deeb S. S. (1989) Blood 74, 1807–1810 [PubMed] [Google Scholar]
- 14. Murthy S., Ryan A., He C., Mallampalli R. K., Carter A. B. (2010) J. Biol. Chem. 285, 25062–25073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Oberley L. W., Spitz D. R. (1984) Methods Enzymol. 105, 457–464 [DOI] [PubMed] [Google Scholar]
- 16. Panus P. C., Radi R., Chumley P. H., Lillard R. H., Freeman B. A. (1993) Free Radic. Biol. Med. 14, 217–223 [DOI] [PubMed] [Google Scholar]
- 17. Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Jaronen M., Arens E., Akerman K., Chan P. H., Koistinaho J. (2008) J. Biol. Chem. 283, 8446–8452 [DOI] [PubMed] [Google Scholar]
- 18. Tephly L. A., Carter A. B. (2007) Am. J. Physiol. Lung Cell Mol. Physiol. 293, L1143–L1155 [DOI] [PubMed] [Google Scholar]
- 19. Venkatachalam P., de Toledo S. M., Pandey B. N., Tephly L. A., Carter A. B., Little J. B., Spitz D. R., Azzam E. I. (2008) Oncogene 27, 20–31 [DOI] [PubMed] [Google Scholar]
- 20. Carter A. B., Hunninghake G. W. (2000) J. Biol. Chem. 275, 27858–27864 [DOI] [PubMed] [Google Scholar]
- 21. Anderson M. E. (1985) Tissue Glutathione, CRC Press, Boca Raton, FL [Google Scholar]
- 22. Griffith O. W. (1980) Anal. Biochem. 106, 207–212 [DOI] [PubMed] [Google Scholar]
- 23. Rom W. N., Bitterman P. B., Rennard S. I., Cantin A., Crystal R. G. (1987) Am. Rev. Respir. Dis. 136, 1429–1434 [DOI] [PubMed] [Google Scholar]
- 24. Panduri V., Weitzman S. A., Chandel N. S., Kamp D. W. (2004) Am. J. Physiol. Lung Cell Mol. Physiol. 286, L1220–1227 [DOI] [PubMed] [Google Scholar]
- 25. Soberanes S., Urich D., Baker C. M., Burgess Z., Chiarella S. E., Bell E. L., Ghio A. J., De Vizcaya-Ruiz A., Liu J., Ridge K. M., Kamp D. W., Chandel N. S., Schumacker P. T., Mutlu G. M., Budinger G. R. (2009) J. Biol. Chem. 284, 2176–2186 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Field L. S., Furukawa Y., O'Halloran T. V., Culotta V. C. (2003) J. Biol. Chem. 278, 28052–28059 [DOI] [PubMed] [Google Scholar]
- 27. Mesecke N., Terziyska N., Kozany C., Baumann F., Neupert W., Hell K., Herrmann J. M. (2005) Cell 121, 1059–1069 [DOI] [PubMed] [Google Scholar]
- 28. Furukawa Y., Torres A. S., O'Halloran T. V. (2004) EMBO J. 23, 2872–2881 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Hess D. T., Matsumoto A., Kim S. O., Marshall H. E., Stamler J. S. (2005) Nat. Rev. Mol. Cell Biol. 6, 150–166 [DOI] [PubMed] [Google Scholar]
- 30. Guo C. J., Atochina-Vasserman E. N., Abramova E., Foley J. P., Zaman A., Crouch E., Beers M. F., Savani R. C., Gow A. J. (2008) PLoS Biol. 6, e266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Ischiropoulos H., Gow A. (2005) Toxicology 208, 299–303 [DOI] [PubMed] [Google Scholar]
- 32. Gilliard N., Heldt G. P., Loredo J., Gasser H., Redl H., Merritt T. A., Spragg R. G. (1994) J. Clin. Invest. 93, 2608–2615 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Mossman B. T., Marsh J. P., Sesko A., Hill S., Shatos M. A., Doherty J., Petruska J., Adler K. B., Hemenway D., Mickey R. (1990) Am. Rev. Respir. Dis. 141, 1266–1271 [DOI] [PubMed] [Google Scholar]
- 34. Krombach F., Gerlach J. T., Padovan C., Burges A., Behr J., Beinert T., Vogelmeier C. (1996) Eur. Respir. J. 9, 984–991 [DOI] [PubMed] [Google Scholar]
- 35. Janssen Y. M., Marsh J. P., Absher M. P., Hemenway D., Vacek P. M., Leslie K. O., Borm P. J., Mossman B. T. (1992) J. Biol. Chem. 267, 10625–10630 [PubMed] [Google Scholar]
- 36. Janssen Y. M., Marsh J. P., Absher M., Borm P. J., Mossman B. T. (1990) Free Radic. Res. Commun. 11, 53–58 [DOI] [PubMed] [Google Scholar]
- 37. Brown N. M., Torres A. S., Doan P. E., O'Halloran T. V. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 5518–5523 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Iñarrea P., Moini H., Rettori D., Han D., Martínez J., García I., Fernández-Vizarra E., Iturralde M., Cadenas E. (2005) Biochem. J. 387, 203–209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Turrens J. F., Boveris A. (1980) Biochem. J. 191, 421–427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Turrens J. F., Alexandre A., Lehninger A. L. (1985) Arch. Biochem. Biophys. 237, 408–414 [DOI] [PubMed] [Google Scholar]
- 41. Brooksbank B. W., Balazs R. (1984) Brain Res. 318, 37–44 [DOI] [PubMed] [Google Scholar]
- 42. Marden J. J., Harraz M. M., Williams A. J., Nelson K., Luo M., Paulson H., Engelhardt J. F. (2007) J. Clin. Invest. 117, 2913–2919 [DOI] [PMC free article] [PubMed] [Google Scholar]







